\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ surgery\ \(977\)\
\-\ \\â\\€\\¢\\ large\\ bifrontal\\,\\ calcified\\,\\ mass\\ arising\\ from\\ the\\ ethmoid\\ roof\ \(0\)\
\-\ \\â\\€\\¢\\ profuse\\ enhancement\ \(0\)\
\-\ \\â\\€\\¢\\ reactive\\ hyperostosis\\ \\(sclerotic\\ bony\\ changes\\)\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ \\"spoke\\-wheel\\"\\ flow\\ voids\\ within\\ center\\ of\\ mass\\.\ \(0\)\
\-\ \\â\\€\\¢\\ massive\\ amount\\ of\\ associated\\ intraaxial\\ vasogenic\\ edema\ \(0\)\
\-\ meningioma\\ ethmoid\\ roof\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ olfactory\\ neuroblastoma\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ hemangiopericytoma\ \(1\)\
\-\ 55\\ year\\ old\\ woman\\ with\\ syncope\\.\ \(1\)\
\-\ history\\ of\\ lymphoma\\ treated\\ many\\ years\\ previously\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.19587679394948598\ \(0\)\
\-\ roof\\:\\ 0\\.14383145178444756\ \(0\)\
\-\ ethmoid\\:\\ 0\\.1385243618743723\ \(0\)\
\-\ spoke\\-wheel\\:\\ 0\\.12243775588842358\ \(0\)\
\-\ profuse\\:\\ 0\\.1128107117139799\ \(0\)\
\-\ meningioma\\:\\ 0\\.0912802593459743\ \(0\)\
\-\ bifrontal\\:\\ 0\\.0891336548773351\ \(0\)\
\-\ olfactory\\:\\ 0\\.08681345925701335\ \(0\)\
\-\ syncope\\:\\ 0\\.0808303632001737\ \(0\)\
\-\ intraaxial\\:\\ 0\\.07888922511162984\ \(0\)\
\-\ hyperostosis\\:\\ 0\\.07773114720969856\ \(0\)\
\-\ hemangiopericytoma\\:\\ 0\\.07086036607308598\ \(0\)\
\-\ voids\\:\\ 0\\.06782906654503017\ \(0\)\
\-\ massive\\:\\ 0\\.06782906654503017\ \(0\)\
\-\ vasogenic\\:\\ 0\\.06424810669361211\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.05933643946800687\ \(0\)\
\-\ center\\:\\ 0\\.05820202237058648\ \(0\)\
\-\ 55\\:\\ 0\\.057537355409785995\ \(0\)\
\-\ reactive\\:\\ 0\\.05617824721528935\ \(0\)\
\-\ sclerotic\\:\\ 0\\.053126192183163355\ \(0\)\
\-\ calcified\\:\\ 0\\.05094477704379229\ \(0\)\
\-\ previously\\:\\ 0\\.049857940975740235\ \(0\)\
\-\ amount\\:\\ 0\\.04956242155286128\ \(0\)\
\-\ arising\\:\\ 0\\.04913060784355529\ \(0\)\
\-\ many\\:\\ 0\\.04878074327649198\ \(0\)\
\-\ bony\\:\\ 0\\.047463273922899236\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.04383383622509551\ \(0\)\
\-\ flow\\:\\ 0\\.03922297051192383\ \(0\)\
\-\ treated\\:\\ 0\\.035525706056720265\ \(0\)\
\-\ years\\:\\ 0\\.0348505991252567\ \(0\)\
\-\ changes\\:\\ 0\\.03401455522548695\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03391942547763174\ \(0\)\
\-\ edema\\:\\ 0\\.03356838179765682\ \(0\)\
\-\ mass\\:\\ 0\\.033012805748543456\ \(0\)\
\-\ enhancement\\:\\ 0\\.031812343973931054\ \(0\)\
\-\ metastatic\\:\\ 0\\.02987651949466792\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.029168542189330793\ \(0\)\
\-\ surgery\\:\\ 0\\.028819431449448263\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.028607631971975595\ \(0\)\
\-\ associated\\:\\ 0\\.028006424470940303\ \(0\)\
\-\ woman\\:\\ 0\\.027415318715123697\ \(0\)\
\-\ large\\:\\ 0\\.025951978219876104\ \(0\)\
\-\ multiple\\:\\ 0\\.024997305603878733\ \(0\)\
\-\ within\\:\\ 0\\.022640714005362245\ \(0\)\
\-\ disease\\:\\ 0\\.019399132516884778\ \(0\)\
\-\ from\\:\\ 0\\.017589384904919615\ \(0\)\
\-\ history\\:\\ 0\\.016391868579265046\ \(0\)\
\-\ year\\:\\ 0\\.013279239851012703\ \(0\)\
\-\ old\\:\\ 0\\.012151869400864646\ \(0\)\
\-\ \\(\\:\\ 0\\.010032801753386951\ \(0\)\
\-\ \\)\\:\\ 0\\.009910245723795903\ \(0\)\
\-\ \\,\\:\\ 0\\.007519724042146871\ \(0\)\
\-\ of\\:\\ 0\\.004854325033249517\ \(0\)\
\-\ the\\:\\ 0\\.001920128954217025\ \(0\)\
\-\ with\\:\\ 0\\.0016250580012484685\ \(0\)\
\-\ \\.\\:\\ 0\\.0009860982249262854\ \(0\)\
